Marieke Brusseel 1 – 3 of 3 publications Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Download search results Subscribe to news feed Add to list Conference Paper C3 Phase Ia study of MIDRIX4-LUNG, a tetravalent autologous dendritic cell immunotherapy, in patients with metastatic non-small cell lung cancer D. Stevens, Joline Ingels (UGent) , Elisabeth Brabants (UGent) , Sandra Van Lint (UGent) , Celine Everaert (UGent) , Karin Weening (UGent) , Kelly Heyns (UGent) , S. Desmet, Pam Devreker (UGent) , Nele Lootens (UGent) , et al. (2025) JOURNAL OF THORACIC ONCOLOGY. In Journal of Thoracic Oncology 20(3, Supplement 1). p.S38-S39 Add to list Journal Article A1 open access Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum Joline Ingels (UGent) , Laurenz De Cock, Dieter Stevens (UGent) , Rupert Mayer (UGent) , Fabien Henri Thery (UGent) , Guillem Sanchez Sanchez, David Vermijlen, Karin Weening (UGent) , Saskia De Smet (UGent) , Nele Lootens (UGent) , et al. (2024) CELL REPORTS MEDICINE. 5(5). Add to list Journal Article A1 open access Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials Joline Ingels (UGent) , Laurenz De Cock, Rupert Mayer (UGent) , Pam Devreker (UGent) , Karin Weening (UGent) , Kelly Heyns (UGent) , Nele Lootens (UGent) , Saskia De Smet (UGent) , Marieke Brusseel (UGent) , Stijn De Munter (UGent) , et al. (2022) CYTOTHERAPY. 24(2). p.213-222
